Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
20/06/2025 20:44
June 20 (Reuters) - Lipella Pharmaceuticals Inc LIPO.PK: LIPELLA PHARMACEUTICALS ANNOUNCES DELISTING FROM NASDAQ CAPITAL MARKET LIPELLA PHARMACEUTICALS INC - DELISTING DUE TO NON-COMPLIANCE WITH NASDAQ LISTING RULES Source text: ID:nGNX9kyGlD Further company coverage: LIPO.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group